Perseus Proteomics Inc
TSE:4882
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
300
837
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Perseus Proteomics Inc
Perseus Proteomics Inc
Income from Continuing Operations
Perseus Proteomics Inc
Income from Continuing Operations Peer Comparison
2160
4587
4974
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Perseus Proteomics Inc
TSE:4882
|
Income from Continuing Operations
-¥1.1B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Income from Continuing Operations
¥5.4B
|
CAGR 3-Years
51%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Income from Continuing Operations
¥21.7B
|
CAGR 3-Years
83%
|
CAGR 5-Years
51%
|
CAGR 10-Years
65%
|
|
|
Takara Bio Inc
TSE:4974
|
Income from Continuing Operations
¥145m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-22%
|
|
S
|
StemRIM Inc
TSE:4599
|
Income from Continuing Operations
¥168.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cuorips Inc
TSE:4894
|
Income from Continuing Operations
-¥632.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Perseus Proteomics Inc's Income from Continuing Operations?
Income from Continuing Operations
-1.1B
JPY
Based on the financial report for Mar 31, 2024, Perseus Proteomics Inc's Income from Continuing Operations amounts to -1.1B JPY.
What is Perseus Proteomics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-47%
Over the last year, the Income from Continuing Operations growth was -40%. The average annual Income from Continuing Operations growth rates for Perseus Proteomics Inc have been -39% over the past three years , -47% over the past five years .
You don't have any saved screeners yet
